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Key findings
 In this study we have developed thresholds for
clinical importance for the recently published com-
puter-adaptive EORTC quality of life measures
(EORTC CAT Core).
 The thresholds from our study have excellent
diagnostic accuracy for the identification of clini-
cally important symptoms and functional health
impairments measured with the EORTC CAT
Core.
What this adds to what was known?
 Our study is the first to present thresholds for clin-
ical importance for the EORTC CAT Core. These
thresholds are based on criteria reflecting the views
of both patients with cancer and health
professionals.
What is the implication and what should change
now?
 The thresholds facilitate interpretation of scores
from the EORTC CAT Core and can be used, for
example, for symptom screening in daily practice
or for calculating symptom prevalence rates from
the EORTC CAT Core.
1. Introduction
In recent years, patient-reported outcomes (PROs) have
become a cornerstone of clinical research and are increas-
ingly being integrated into daily practice. This has been
fostered by the availability of reliable and well-validated
PRO measures that are derived from sophisticated develop-
ment procedures [1e3].
PRO measures based on Item Response Theory (IRT), a
probabilistic measurement theory to determine psychomet-
ric characteristics of PRO measures, have only recently
been introduced in the medical field, although they have
a long tradition of use in educational testing and psycholog-
ical assessments [4,5]. Measures developed according to
IRT models are more versatile than traditional question-
naires that rely on classical test theory [6]. An important
advantage of IRT-based PRO measures is that they allow
one to administer different questions on a given topic to
different patients while still obtaining comparable scores
across patients on the same metric [7].
Over the last few years, the European Organisation for
Research and Treatment of Cancer (EORTC) Quality of
Life Group (QLG) has developed item banks based on
IRT models to enhance measurement for each of thefunctional health and symptom domains of the EORTC
QLQ-C30 questionnaire. These so-called EORTC Com-
puter Adaptive Testing (CAT) Core measures [8] consist
of item banks with validated questions with well-defined
measurement characteristics. The item banks allow for
two modes of administration, CAT and static questionnaire
short forms.
CAT assessments rely on an algorithm [2] to tailor the
questions to the individual patient, based on his/her earlier
responses. Static short forms are predefined sets of items
from an item bank typically selected to maximize measure-
ment precision for the score distribution of a specific pa-
tient population. Although CAT requires electronic
questionnaire administration (e.g., on a tablet personal
computer or mobile phone), static short forms can also be
administered on paper. The EORTC CAT Core item banks
have been shown to have higher measurement precision
than the QLQ-C30 while providing scores that are compat-
ible with the original QLQ-C30 [8].
Scores from the EORTC CAT Core are presented on a
T-score metric, which is a standardized metric with a
mean of 50 and a standard deviation (SD) of 10 points.
Standardization is reached through the use of a reference
population [9]. This scoring method is different from the
scoring of the QLQ-C30, which presents scores on a
0e100 metric derived from summing responses to individ-
ual questions and the use of linear transformation [10].
Because T-scores describe the difference from the refer-
ence population mean in SD units, they are more informa-
tive than simple sum scores. Although this facilitates score
interpretation, what constitutes a clinically important
symptom or functional health impairment on such a metric
is not well defined.
Thresholds for clinical importance (TCIs) are needed
to calculate prevalence rates for clinically important
symptoms and functional impairments from metric
EORTC CAT Core scores and to improve the applica-
bility of this instrument for symptom screening and
monitoring in daily clinical practice. Routine collection
of PRO data in clinical practice has been demonstrated
to improve symptom management and even to improve
survival rates [11e14].
Such thresholds improve the interpretability of scores
from individual patients at a single time point, which is
conceptually different from minimal important [15,16] used
for evaluating score change over time or differences be-
tween patient groups.
In a previous analysis [17], we established TCIs for
the scales of the EORTC QLQ-C30 and found excellent
diagnostic accuracy for all scales as well as invariance
of thresholds across various patient groups. The EORTC
CAT Core covers the same functional health and symp-
tom domains as the EORTC QLQ-C30 but provides more
flexibility regarding assessment length (number of ques-
tions) and improved measurement precision [8,18].
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score interpretation may make the EORTC CAT Core
particularly useful for patient monitoring in daily
practice.
The objectives of the present study were to establish
TCIs for the EORTC CAT Core and to determine the sensi-
tivity and specificity of these thresholds when used for
identification of clinically important symptoms and func-
tional health impairments.2. Methods
2.1. Sample
For this cross-sectional study, we recruited cancer pa-
tients (any diagnosis, type of treatment, or treatment status)
in six European countries (Austria, Italy, the Netherlands,
Poland, Spain, and the United Kingdom). For inclusion in
the study, patients had to be aged 18 years or older, speak
the primary language of their country of residence, and pro-
vide written informed consent. Patients were excluded from
the study if they had serious cognitive impairment that
would prohibit them from completing questionnaires. Pa-
tients completed the study questionnaires (a short form
based on the EORTC CAT Core and anchor items on clinical
importance) either on paper or electronically via the soft-
ware program Computer-Based Health Evaluation System
CHES [19]. This analysis relies on the same data set that
has been used previously for establishing TCIs for the
EORTC QLQ-C30 [17].
Ethical approval was obtained from the local ethics com-
mittees, if required (Medical University of Innsbruck: AN-
2014-0012; East & North Hertfordshire NHS Trust: IRAS
code 145602; Netherlands Cancer Institute: METC-AVL
P17TRE).
2.2. EORTC CAT core measures
The EORTC CAT Core item banks comprise a total of
260 items (including all items from the QLQ-C30) orga-
nized into 14 item banks, each comprising between 7 and
34 items to cover one of the five functional health and nine
symptom domains of the EORTC QLQ-C30 questionnaire.
The functional health domains comprise physical func-
tioning (PF), role functioning (RF), social functioning
(SF), emotional functioning (EF), and cognitive functioning
(CF). The symptom domains cover fatigue (FA), pain (PA),
nausea/vomiting (NV), appetite loss (AP), dyspnea (DY),
sleep disturbances (SL), diarrhea (DI), constipation (CO),
and financial impact of disease (FI). The EORTC CAT Core
presents results as T-scores that are based on a representa-
tive general population sample of 11,343 individuals from
11 European countries [9]. Higher scores on the functioning
scales indicate higher levels of functioning, whereas higher
scores on the symptom scales represent more symptom
burden.In our study, we administered static short forms that
were created from the EORTC CAT Core item banks. Short
forms were used instead of adaptive assessments so that
data could also be collected in a paper-pencil format. For
each domain, we included the items from the QLQ-C30
and additional items from the item banks that increased
measurement precision in the range where we expected, a
priori, the TCIs to be located (i.e., between the 75th to
90th percentile of general population scores [20] for symp-
tom domains and between the 10th and 25th percentile for
functional health domains). In total, the short forms
comprised seven items for PF and EF, five items for FA,
and four items for all other domains.2.3. Anchor items for establishing thresholds
In this study, we used the same anchor items as have been
used previously to establish TCIs for the EORTC QLQ-C30.
Details on the rationale for defining anchor items have been
published elsewhere [17]. Briefly, following a mixed
methods study in 150 cancer patients and health profes-
sionals [21] and a consensus meeting within the EORTC
QLG, we defined clinical importance of a symptom or func-
tional health impairment in terms of three criteria: limita-
tions in everyday life, worries by the patient or his/her
family/partner, and the need for help or care.
Specifically, the anchor questions used for establishing
TCIs were the following:
 Limitations: ‘‘Has your SYMPTOM/PROBLEM
limited your daily life?’’
 Worries: ‘‘Has your SYMPTOM/PROBLEM caused
you or your family/partner to worry?’’
 Need for help: ‘‘Have you needed any help or care
because of your SYMPTOM/PROBLEM?’’
For RF, SF, and PA, we did not ask about limitations
because interference with daily life is already included in
the EORTC CAT Core for these three domains. In line with
previous studies [17,22], we used the standard QLQ-C30
response format for the anchor items (a 4-point Likert scale
with responses choices ‘‘not at all,’’ ‘‘a little,’’ ‘‘quite a bit,’’
and ‘‘very much’’). A patient was categorized as a case (i.e.,
as having a clinically important problem/symptom) if (s)he
selected ‘‘quite a bit’’ or ‘‘very much’’ on any of the anchor
items. If neither of these two categories was selected, patients
were categorized as noncases.2.4. Statistical analysis
Descriptive statistics for the EORTC CAT Core are
given as means and SDs, separately for cases and noncases,
as defined previously. Differences between the two groups
are reported in terms of absolute differences on the T-score
metric and as effect sizes (ES; Cohen’s d).
To investigate diagnostic accuracy and to establish
TCIs, we used receiver operating characteristic (ROC)
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case) derived from the anchor items was used as the cri-
terion and the EORTC CAT Core score as the predictor. In
ROC analysis, the area under the curve (AUC) reflects
how well a predictor variable discriminates between cases
and noncases. An AUC above 0.80 indicates excellent
discrimination [23].
TCIs were determined based on the following stepwise
decision rule that gave greater weight to sensitivity than to
specificity: if possible, we selected a TCI providing
maximum sensitivity with a specificity O0.80 (requiring
the sensitivity to be O0.90). If such a TCI was not found,
we selected a TCIwithmaximum sensitivity and a specificity
O0.70 (requiring sensitivity to beO 0.80). Finally, if no pre-
vious step allowed definition of a TCI, we selected a TCIwith
a sensitivityO0.80 and the highest achievable specificity.
We emphasized sensitivity over specificity because the
main use of the TCIs will be for screening in daily practice,
where underidentification of symptoms may be more prob-
lematic than ‘‘false alarms.’’ As a sensitivity analysis of this
decision, we also calculated TCIs obtained by giving equal
weight of sensitivity and specificity by calculating the You-
den J index (i.e., the sum of sensitivity and specificity
minus 1 [24]) and contrasting this index for our TCIs with
the maximum obtainable Youden J value.
For each of the 14 domains of the EORTC CAT Core,
we investigated the robustness of diagnostic accuracy
across various patient groups. For this purpose we calcu-
lated the AUC for 14 different patient groups, defined by
age (below/above 60 years), sex, treatment intention (cura-
tive/palliative), treatment status (on/off), comorbidity (no/
yes), and European region (Western Europe [Austria and
the Netherlands], Southern Europe [Italy and Spain],
Eastern Europe [Poland], and the United Kingdom). For
each patient group we investigated if the AUC exceeded
the threshold for excellent discrimination of 0.80.
For each domain we used a multivariate binary logistic
regression model to evaluate the invariance of TCIs across
these patient groups. Themodel included the above grouping
variables and the EORTC CAT Core score as independent
variables and the binary criterion variable (case/noncase)
as dependent variable. In such a model the grouping vari-
ables indicate between-group differences regarding the
probability of being a case for a specific EORTC CAT Core
score, that is, a difference in TCIs between groups. For sta-
tistically significant grouping variables (P ! 0.01), we
investigated group-specific TCIs using the previously
mentioned decision rule within each patient group.
The sample size for this study was determined on the ba-
sis of an a priori power analysis for the ROC analysis. This
analysis showed that a sample of 500 patients (assuming
33% cases) provides a power of 0.80 to demonstrate (with
a two-sided alpha of 0.05) that the AUC is above 0.80 if the
observed AUC is 0.865. The observed AUC was estimated
based on results from a previous pilot study [22]. The po-
wer analysis was conducted with PASS 11.0 [25].3. Results
3.1. Patient characteristics
Between November 2016 and November 2018, we re-
cruited 502 patients, of whom 498 (mean age 60.4 years,
SD 12.7; 55.2% women) provided complete questionnaires
that could be used for the analysis. At the time of assess-
ment, most patients (76.7%) were on-treatment (60.6%
with curative intention). Further details are reported in
Table 1 and elsewhere [17].
The percentage of cases on the EORTC CAT CORE do-
mains, based on the criteria for clinical importance
described previously, ranged from 8.3% for DI to 54.5%
for PF, with a median prevalence across domains of
18.1% (see Table 2).
3.2. Thresholds for clinical importance
For the functional health domains, we observed the
largest difference between cases and noncases for RF
(44.5 vs. 30.2 points, ES 5 1.76) and the smallest differ-
ence for SF (45.9 vs. 35.6 points, ES 5 1.34). For symp-
tom scales, differences ranged from an ES of 1.65 (SL: 50.1
vs. 63.0 points) to an ES of 2.79 (NV: 51.5 vs. 78.9 points).
The median ES was 1.48 for the functioning scales and
2.13 for the symptom scales. Further details are reported
in Table 2.
Diagnostic accuracy in terms of AUC was above 0.90 for
9 of the 14 scales. The largest AUCs were observed for FA,
AP, CO, DI, FI (all AUC5 0.94), and the lowest for PF and
SF (both 0.84).
TCIs for functioning scales ranged from 37 points for
RF to 46 points for PF and EF. For symptom scales, the
lowest TCI was observed for SL (55 points) and the highest
for AP (63 points). Sensitivity of the TCIs ranged from 0.80
(SF) to 0.96 (CO), with a median value across domains of
0.91. Specificity was lowest for PF (0.66) and highest for
fatigue (0.84), with a median of 0.77. For further details,
see Table 3 and Figure 1.
As mentioned previously, our study relied on static short
forms from the EORTC CAT Core item banks that were
based on a priori assumptions about the TCIs. Higher mea-
surement precision (i.e., item information) at the TCI al-
lows for more accurate classification of patients with
scores close to the TCI, resulting in an increase of the sensi-
tivity and specificity of the scale. For an illustration of how
measurement precision at the TCI differs, see Figure 2
showing as an example the five-item QLQ-C30 PF scale
and a five-item static short form designed to maximize
the measurement precision at the TCI.
3.3. Sensitivity analysis
Investigating group-specific AUCs in 14 patient groups
for the 14 functional health and symptom domains, we
found that only 5 of 196 AUCs were below 0.80 (the
Table 1. Descriptive statistics for sociodemographic and clinical
variables (n 5 498)
Variable Mean (SD) Range
Age
60.4 (12.7) 19e87
n %
Sex
Women 272 55.2
Men 221 44.8
Missing data 5
Diagnosis
Breast cancer 117 23.6
Hematological malignancy 66 13.3
Lung cancer 49 9.9
Prostate cancer 48 9.7
Colorectal cancer 42 8.5
Head and neck cancer 39 7.9
Lymphoma 37 7.5
Gynecologic cancer 29 5.9
Stomach cancer 12 2.4
Brain cancer 10 2.0
Other 46 9.3
Missing data 3
UICC stagea
I 61 16.1
II 100 26.4
III 79 20.8
IV 139 36.7
Missing data 16
Comorbidity
No 272 59.0
Yes 189 41.0
Missing data 37
Treatment intention
Curative 282 60.6
Palliative 183 39.4
Missing data 33
Current treatment
No current treatment 115 23.3
Current treatment 379 76.7
Surgeryb 135 35.6
Chemotherapyb 232 61.2
Radiotherapyb 127 33.5
Otherb 81 21.4
Missing data 4
Abbreviations: UICC, Union for International Cancer Control.
a Only reported for patients with solid tumors.
b More than one treatment is possible, so the percentages for the
treatment modalities do not sum up to 100%.
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Kingdom (AUC 5 0.77), CF in Southern Europe (0.77),
EF in Western Europe (0.78), PF in Western Europe(0.79), and CF in patients on-treatment (0.79). The 95%
confidence intervals of all of these five AUCs included
0.80.
Our sensitivity analysis of the robustness of TCIs across
patient groups using a logistic regression model indicated
statistically significant (P ! 0.01) differences in TCIs for
6 of the 196 combinations of patient groups and domains.
When applying the previously mentioned decision rule
for determining TCIs to these individual patient groups
and domains, we found that the overall TCI differed by
more than one point from the group-specific TCI for the
following scales: PF in patients !60 years, TCI 5 48
(sensitivity 0.80 and specificity 0.64); PF in patients aged
60 years, TCI 5 44 (sensitivity 0.87 and specificity
0.73); SF in Southern Europe, TCI 5 43 (sensitivity 0.86
and specificity 0.62); FA in Eastern Europe, TCI 5 55
(sensitivity 0.95 and specificity 0.90); DY in the United
Kingdom, TCI 5 62 (sensitivity 0.96 and specificity
0.84); and DY in Eastern Europe, TCI 5 58 (sensitivity
0.91 and specificity 0.73). For all these domains, the differ-
ence between the group-specific and the overall TCI was 2
points.
Comparing the Youden J index for the TCIs derived
from our decision rule against the maximum obtainable
value, we found a difference exceeding 0.05 for three do-
mains: for PF, a threshold of 44 provides a Youden J index
that is larger by 0.077; for EF, a threshold of 42 increases
Youden J by 0.061; and for CO, a threshold of 63 has a
Youden J higher by 0.074.4. Discussion
We have established TCIs for all domains of the EORTC
CAT Core, the adaptive PRO instrument recently developed
by the EORTC Quality of Life Group. We found excellent
diagnostic accuracy for the EORTC CAT Core measures in
identifying clinically important functional health impair-
ments and symptoms, which facilitated defining TCIs with
high sensitivity and, in general, high specificity. TCIs were
in the range of 4e13 points (i.e., 0.4 to 1.3 SD units) from
the normative general population mean of 50 points. The
sensitivity analysis indicated that, with very few excep-
tions, the diagnostic accuracy of the EORTC CAT Core
measure was excellent for the patient groups analyzed.
Evaluating the performance of the TCIs in specific patient
groups, we found minor differences in the optimal TCI
for a small number of combinations of domains and patient
groups, most notably a smaller impairment in PF being of
clinical importance in patients aged !60 years, compared
with those aged O60 years. In general, the EORTC CAT
Core outperformed the EORTC QLQ-C30 in terms of diag-
nostic accuracy [17], resulting in better sensitivity and
specificity of the TCIs. This makes the use of the EORTC
CAT Core attractive in daily clinical practice, where high
measurement precision is desirable at the individual patient
Table 2. Comparison of EORTC CAT Core in patients with clinically important problems/symptoms (cases) and those without (noncases)
EORTC CAT Core scale
Noncases Cases
Mean difference Pooled SD Effect sizeaPrevalence (%) Mean SD Prevalence (%) Mean SD
Functioning scales
Physical functioning 45.5 50.0 7.8 54.5 38.2 9.4 11.8 8.7 1.36
Role functioning 75.4 44.5 8.6 24.6 30.2 6.4 14.3 8.1 1.76
Social functioning 81.5 45.9 7.9 18.5 35.6 7.0 10.3 7.7 1.34
Emotional functioning 72.0 52.0 7.8 28.0 39.5 6.3 12.5 7.5 1.67
Cognitive functioning 88.5 49.1 8.2 11.5 36.9 8.6 12.2 8.2 1.48
Symptom scales
Fatigue 64.5 50.5 7.4 35.5 64.9 6.6 14.4 7.1 2.02
Pain 82.0 47.3 8.1 18.0 64.2 7.1 16.9 7.9 2.13
Nausea/vomiting 89.7 51.5 9.1 10.3 78.9 14.9 27.4 9.8 2.79
Dyspnea 80.8 51.2 8.9 19.2 66.2 5.1 15.0 8.4 1.79
Sleep disturbances 81.8 50.1 8.1 18.2 63.0 6.7 12.9 7.8 1.65
Appetite loss 89.1 54.1 10.5 10.9 72.6 6.0 18.5 10.1 1.83
Constipation 90.1 49.6 9.5 9.9 70.0 8.0 20.3 9.4 2.17
Diarrhea 91.7 50.2 9.9 8.3 72.9 8.1 22.7 9.8 2.32
Financial impact 85.8 48.6 7.5 14.2 69.0 8.8 20.4 7.7 2.65
Abbreviations: SD, standard deviation.
a Effect size Cohen’s d 5 mean difference/pooled SD.
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relying on computer-adaptive assessments that maximize
measurement precision of the EORTC CAT Core for scores
close to the TCIs. For centers relying on paper-pencil data
collection or using software not capable of administering
CAT measures, static short forms can be created that maxi-
mize measurement precision around the TCI to allow for
accurate identification of clinically important problems
(see Figure 2).Table 3. Results of the receiver operating characteristic (ROC) analysis and
EORTC CAT Core scale TCI Sensitivity
Functioning scales
Physical functioning 46 0.82
Role functioning 37 0.84
Social functioning 41 0.80
Emotional functioning 46 0.86
Cognitive functioning 45 0.82
Symptom scales
Fatigue 57 0.92
Pain 56 0.90
Nausea/vomiting 58 0.90
Dyspnea 60 0.93
Sleep disturbances 55 0.91
Appetite loss 63 0.94
Constipation 57 0.96
Diarrhea 62 0.95
Financial impact 58 0.93
Abbreviations: AUC, area under the curve; CI, confidence interval; TCI,
Please note that for the functioning scales, scoring equal to or below the
scales, scores equal to or above the TCI indicate such a problem.With an intention similar to our study, a series of studies
have established thresholds for severity categories for
several Patient-Reported Outcomes Measurement Informa-
tion System (PROMIS) measures [26e28]. However, these
studies used a quite different methodological approach,
relying on case vignettes describing a range of possible
severity levels for each domain. The case vignettes were
created based on item content and responses and described
symptom levels that each differed by 5 points on a T-scorethresholds for clinical importance
Specificity AUC 95% CI
0.66 0.84 0.80e0.87
0.79 0.91 0.88e0.94
0.69 0.84 0.79e0.89
0.71 0.89 0.86e0.93
0.67 0.85 0.79e0.90
0.84 0.94 0.91e0.96
0.79 0.93 0.90e0.96
0.82 0.92 0.88e0.97
0.77 0.93 0.91e0.95
0.76 0.89 0.86e0.93
0.75 0.94 0.91e0.96
0.73 0.94 0.90e0.97
0.82 0.94 0.90e0.98
0.83 0.94 0.91e0.97
threshold for clinical importance.
TCI indicates a clinically important problem, whereas for the symptom
46
37
41
46
45
57
56
58
60
55
63
57
62
58
30 35 40 45 50 55 60 65 70
Func?oning scales:
Physical Func?oning (PF)
Role Func?oning (RF)
Social Func?oning (SF)
Emo?onal Func?oning (EF)
Cogni?ve Func?oning (CF)
Symptom scales:
Fa?gue (FA)
Pain (PA)
Nausea/Vomi?ng (NV)
Sleep Disturbances (SL)
Dyspnoea (DY)
Appe?te Loss (AP)
Cons?pa?on (CO)
Diarrhoea (DI)
Financial Impact (FI)
EORTC CAT Core Thresholds for Clinical Importance (TCIs)
Fig. 1. Thresholds for clinical importance (TCIs) for the functioning and symptom scales of the EORTC CAT Core. TCIs are shown inside the bars.
Patient scores in the orange range of the bar (i.e., equal or below the TCI for functioning scales, and equal or above the TCI for symptom scales)
indicate clinically important problems or symptoms. (For interpretation of the references to color in this figure legend, the reader is referred to the
Web version of this article.)
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ranked and categorized as describing normal, mild, moder-
ate, or severe symptom levels by clinicians and patients
[27,28] or by clinicians only [26]. Comparing classifica-
tions by patients and clinicians, thresholds were fairly
consistent, with patients sometimes rating symptom de-
scriptions as more severe [27] and sometimes as less
severe [28].Fig. 2. Item information curves showing measurement precision for the 5-i
from the EORTC CAT Core item bank that was created specifically to maxim
line).Although the PROMIS measures and the EORTC CAT
Core both present scores on a T-score metric, comparability
of the thresholds is limited because of differences between
the measures in terms of content and measurement charac-
teristics, the normative population underlying the scoring
(the United States vs. Europe), and the methodology used
to establish the thresholds. In addition, a shortcoming of
the case vignette method is that the criteria for setting thetem QLQ-C30 Physical Functioning scale and for a 5-item short-form
ize measurement precision for scores close to the TCI (vertical black
124 J.M. Giesinger et al. / Journal of Clinical Epidemiology 117 (2020) 117e125thresholds are not as explicit as in our study and the sensi-
tivity and specificity for the established thresholds are not
available, thus not allowing a comparison with our TCIs
in this regard. However, consistent with our study, there
was also substantial variation in thresholds across domains
for the PROMIS measures, and for certain domains (e.g.,
pain and fatigue [26]), thresholds were closer to the norma-
tive mean of 50 than one might expect. In fact, for some of
the PROMIS measures, the general population mean over-
lapped with the categories for mild symptom levels
[27,28]. This could indicate a response shift phenomenon
[29], resulting in an underestimation of the true difference
between cancer patients and the general population but may
also reflect the high percentage of individuals suffering
from (chronic) diseases in the general population. In the
normative sample for the EORTC CAT Core [9], for
example, 61.0% of the participants from the general popu-
lation reported at least one health condition, with chronic
pain (23%), arthritis (13%), and diabetes (10%) being most
common.
Development of thresholds for PRO measures has been
recommended in the literature because the interpretation
of scores on abstract metrics has been identified as one of
the major barriers to the use of PRO measures in daily clin-
ical practice [30]. The TCIs for the EORTC CAT Core can
be integrated into software used for routine PRO moni-
toring to improve graphical presentation of PRO results
(e.g., use of color-coding or reference lines [31,32]). In
addition, TCIs make PRO scores more actionable and sup-
port the linking of PRO results to clinical decision-making
[33,34]. Our results provide a key component for the suc-
cessful implementation of the EORTC CAT Core into daily
clinical practice, where its flexibility and measurement pre-
cision at the individual patient level may be particularly
important.
A limitation of our study is that we have not used CAT
assessments, but short forms that were created to maximize
measurement precision in the range where we expected the
TCIs. With CAT assessments or short forms targeting the
now known TCIs more precisely, a higher diagnostic accu-
racy may be obtained, implying that the AUCs reported in
our study may actually underestimate the diagnostic accu-
racy obtainable with the EORTC CAT Core measure.
A strength of our methodological approach is that we
were able to relate the thresholds to explicit criteria that
have been developed carefully, relying on interviews with
patients and health care professionals, as well as on input
from PRO experts in the EORTC QLG [17,21]. The clear
definition allows for a better understanding of the actual
meaning of the thresholds. Furthermore, our empirical
approach allowed us to estimate the sensitivity and speci-
ficity of the TCIs and to conduct a detailed analysis of
invariance across patient groups.
In conclusion, we have established TCIs for the EORTC
CAT Core measure that will facilitate the use of this mea-
sure for PRO monitoring in clinical practice. In clinicalresearch, the TCIs may be used for converting metric T-
scores to symptom prevalence rates that may be easier to
interpret.CRediT authorship contribution statement
Johannes M. Giesinger: Conceptualization, Methodol-
ogy, Formal analysis, Writing - original draft, Data cura-
tion, Writing - review & editing. Fanny L.C. Loth:
Formal analysis, Writing - original draft, Data curation,
Writing - review & editing. Neil K. Aaronson: Conceptu-
alization, Methodology, Data curation, Writing - review &
editing. Juan I. Arraras: Data curation, Writing - review
& editing. Giovanni Caocci: Data curation, Writing - re-
view & editing. Fabio Efficace: Data curation, Writing -
review & editing. Mogens Groenvold: Writing - review
& editing. Marieke van Leeuwen: Data curation, Writing
- review & editing. Morten Aa Petersen: Writing - review
& editing. John Ramage: Data curation, Writing - review
& editing. Krzysztof A. Tomaszewski: Data curation,
Writing - review & editing. Teresa Young: Data curation,
Writing - review & editing. Bernhard Holzner: Conceptu-
alization, Methodology, Data curation, Writing - review &
editing.References
[1] Sprangers MA, Cull A, Bjordal K, Groenvold M, Aaronson NK. The
European Organization for Research and Treatment of Cancer.
Approach to quality of life assessment: guidelines for developing
questionnaire modules. EORTC study group on quality of life. Qual
Life Res 1993;2:287e95.
[2] Petersen MA, Groenvold M, Aaronson NK, Chie WC, Conroy T,
Costantini A, et al. Development of computerised adaptive testing
(CAT) for the EORTC QLQ-C30 dimensions - general approach and
initial results for physical functioning. Eur JCancer 2010;46(8):1352e8.
[3] Reeve BB, Hays RD, Bjorner JB, Cook KF, Crane PK, Teresi JA, et al.
Psychometric evaluation and calibration of health-related quality of
life item banks: plans for the Patient-ReportedOutcomesMeasurement
Information System (PROMIS). Med Care 2007;45:S22e31.
[4] Wright BD, Stone MH. Best test design. Chicago, IL: MESA Press;
1979.
[5] Rasch G. Studies in mathematical psychology: I. Probabilistic models
for some intelligence and attainment tests. Oxford, England: Nielsen
& Lydiche; 1960.
[6] DeVellis RF. Classical test theory. Med Care 2006;44:S50e9.
[7] Van Der Linden W, Hambleton RIn: Handbook of Item Response
Theory, 3. Boca Raton, London, New York: CRC Press Inc; 2016.
[8] Petersen MA, Aaronson NK, Arraras JI, Chie WC, Conroy T,
Costantini A, et al. The EORTC CAT Core-The computer adaptive
version of the EORTC QLQ-C30 questionnaire. Eur J Cancer 2018;
100:8e16.
[9] Liegl G, Petersen MA, Groenvold M, Aaronson NK, Costantini A,
Fayers PM, et al. Establishing the European Norm for the health-
related quality of life domains of the computer-adaptive test EORTC
CAT Core. Eur J Cancer 2019;107:133e41.
[10] Fayers PM, Aaronson NK, Bjordal K, Curran D, Grønvold M.
EORTC QLQ-C30 scoring manual. Brussels: Eortc; 1999.
[11] Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, et al.
Overall survival results of a trial assessing patient-reported outcomes
125J.M. Giesinger et al. / Journal of Clinical Epidemiology 117 (2020) 117e125for symptom monitoring during routine cancer treatment. JAMA
2017;318:197e8.
[12] Denis F, Basch E, Septans AL, Bennouna J, Urban T, Dueck AC,
et al. Two-year survival comparing web-based symptom monitoring
vs routine surveillance following treatment for lung cancer. JAMA
2019;321:306e7.
[13] Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, et al.
Symptom monitoring with patient-reported outcomes during routine
cancer treatment: a randomized controlled trial. J Clin Oncol 2016;
34:557e65.
[14] Basch E, Barbera L, Kerrigan CL, Velikova G. Implementation of
patient-reported outcomes in routine medical care. Am Soc Clin On-
col Educ Book 2018;38:122e34.
[15] Coon CD, Cappelleri JC. Interpreting change in scores on patient-
reported outcome instruments. Ther Innov Regul Sci 2016;50(1):
22e9.
[16] Ousmen A, Touraine C, Deliu N, Cottone F, Bonnetain F, Efficace F,
et al. Distribution- and anchor-based methods to determine the mini-
mally important difference on patient-reported outcome question-
naires in oncology: a structured review. Health Qual Life Outcomes
2018;16(1):228.
[17] Giesinger J, Loth F, Aaronson N, Arraras J, Caocci G, Efficace F,
Groenvold M, van Leeuwen M, Petersen M, Ramage J,
Tomaszewski K, Young T, Holzner B. Establishing thresholds for
clinical importance to improve interpretation of the EORTC QLQ-
C30 in daily clinical practice and research. J Clin Epidemiol 2019.
[18] Petersen MA, Aaronson NK, Arraras JI, Chie WC, Conroy T,
Costantini A, et al. The EORTC computer-adaptive tests measuring
physical functioning and fatigue exhibited high levels of measure-
ment precision and efficiency. J Clin Epidemiol 2013;66:330e9.
[19] Holzner B, Giesinger JM, Pinggera J, Zugal S, Schopf F,
Oberguggenberger AS, et al. The computer-based health evaluation
system (CHES): a software for electronic patient-reported outcome
monitoring. BMC Med Inform Decis Mak 2012;12(1):126.
[20] van de Poll-Franse LV, Mols F, Gundy CM, Creutzberg CL, Nout RA,
Verdonck-de Leeuw IM, et al. Normative data for the EORTC QLQ-
C30 and EORTC-sexuality items in the general Dutch population.
Eur J Cancer 2011;47(5):667e75.
[21] Giesinger JM, Aaronson NK, Arraras JI, Efficace F, Groenvold M,
Kieffer JM, et al. A cross-cultural convergent parallel mixed methods
study of what makes a cancer-related symptom or functional health
problem clinically important. Psychooncology 2018;27(2):548e55.
[22] Giesinger JM, Kuijpers W, Young T, Tomaszewski KA, Friend E,
Zabernigg A, et al. Thresholds for clinical importance for four keydomains of the EORTC QLQ-C30: physical functioning, emotional
functioning, fatigue and pain. Health Qual Life Outcomes 2016;14:
87.
[23] Hosmer D, Lemeshow S, Sturdivant R. Applied logistic regression.
Third edition. Hoboken, New Jersey: John Wiley & Sons; 2013.
[24] Youden WJ. Index for rating diagnostic tests. Cancer 1950;3(1):
32e5.
[25] NCSS-LCC. PASS - Power analysis and sample size. Kaysville (US):
NCSS-LCC; 2011.
[26] Cella D, Choi S, Garcia S, Cook KF, Rosenbloom S, Lai JS, et al.
Setting standards for severity of common symptoms in oncology us-
ing the PROMIS item banks and expert judgment. Qual Life Res
2014;23:2651e61.
[27] Nagaraja V, Mara C, Khanna PP, Namas R, Young A, Fox DA, et al.
Establishing clinical severity for PROMIS((R)) measures in adult pa-
tients with rheumatic diseases. Qual Life Res 2018;27:755e64.
[28] Cook KF, Victorson DE, Cella D, Schalet BD, Miller D. Creating
meaningful cut-scores for Neuro-QOL measures of fatigue, physical
functioning, and sleep disturbance using standard setting with pa-
tients and providers. Qual Life Res 2015;24:575e89.
[29] Taminiau-Bloem EF, van Zuuren FJ, Koeneman MA, Rapkin BD,
Visser MR, Koning CC, et al. A ’short walk’ is longer before radio-
therapy than afterwards: a qualitative study questioning the baseline
and follow-up design. Health Qual Life Outcomes 2010;8:69.
[30] Snyder C, Brundage M, Rivera YM, Wu AW. A PRO-cision medicine
methods toolkit to address the challenges of personalizing cancer
care using patient-reported outcomes: introduction to the supplement.
Med Care 2019;57(Suppl 5 Suppl 1):S1e7.
[31] Loth F, Holzner B, Sztankay M, Bliem H, Raoufi S, Rumpold G,
et al. Cancer patients’ understanding of longitudinal EORTC QLQ-
C30 scores presented as bar charts. Patient Educ Couns 2016;
99(12):2012e7.
[32] Snyder CF, Smith KC, Bantug ET, Tolbert EE, Blackford AL,
Brundage MD, et al. What do these scores mean? Presenting pa-
tient-reported outcomes data to patients and clinicians to improve
interpretability. Cancer 2017;123(10):1848e59.
[33] Absolom K, Gibson A, Velikova G. Engaging patients and clinicians
in online reporting of adverse effects during chemotherapy for can-
cer: the eRAPID system (electronic patient self-reporting of adverse
events: patient information and aDvice). Med Care 2019;57:S59e65.
[34] Girgis A, Durcinoska I, Arnold A, Delaney GP. Interpreting and
acting on the PRO scores from the patient-reported outcomes for
personalized treatment and care (PROMPT-Care) eHealth system.
Med Care 2019;57:S85e91.
